Updated Drug Shortage Information for December 10, 2024

Dec 102024
 

New Shortages December 10, 2024 Adalimumab-Adbm Injection (Discontinuation)   December 9, 2024 Lodoxamide Tromethamine Solution (Discontinuation) Tiagabine Hydrochloride Tablet (Discontinuation) Tigecycline Injection (Discontinuation)   December 6, 2024 Sodium Chloride

Updated Drug Shortage Information for December 5, 2024

Dec 052024
 

New Shortages December 5, 2024 Clindamycin Hydrochloride Capsule (Discontinuation) Cyclosporine Oral Solution (Discontinuation) Desmopressin Acetate Injection (Discontinuation) Digoxin Tablet (Discontinuation) Edaravone Injection (Discontinuation) Imatinib Mesylate Tablet (Discontinuation) Pantoprazole Sodium Injection (Discontinuation)

FDA Novel Drug Approvals – November 2024

Dec 012024
 

Drug Name Active Ingredient(s) Approval Date FDA-Approved Use on Approval Date Press Release Drug Trials Snapshot Iomervu iomeprol 11/27/2024 For use as a radiographic contrast

FDA Drug Safety Information for November 19, 2024

Nov 192024
 

Date Brand Name(s) Description Type Reason Company  11/19/2024 Par Pharmaceutical Clonazepam Orally Disintegrating Tablets, USP (C-IV) Drugs Mislabeled with the incorrect strength on the carton

FDA Novel Drug Approvals – October 2024

Nov 012024
 

Drug Name Active Ingredient(s) Approval Date FDA-Approved Use on Approval Date Press Release Drug Trials Snapshot Orlynvah sulopenem etzadroxil, probenecid 10/25/2024 To treat uncomplicated urinary

FDA Drug Safety Information for October 16, 2024

Oct 162024
 

Date Brand Name(s) Description Type Reason Company  10/16/2024 STASKA Pharmaceuticals Ascorbic Acid Solution for Injection Drugs Device & Drug Safety – Presence of glass particulates

 Older Entries  Newer Entries